ReviewOpen veterinary journal2025
Global initiatives to phase-out colistin use in food-producing animals.
Review in Open veterinary journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- [Plasmid-mediated colistin resistance in pathogenic bacteria].Revista medica del Instituto Mexicano del Seguro Social · 2026Pooled it
- Antimicrobial resistance in meat and meat products from Asia: An urgent one health challenge- a systematic review and meta-analysis.Poultry science · 2025Pooled it
- Multidrug-ResistantFoods (Basel, Switzerland) · 2026Article
- Review
- Acquired mutations in transcriptional regulatorAntimicrobial agents and chemotherapy · 2026Article
- Comparative evaluation of post-mortem methods for detection of diarrhoea in early-life piglets.Porcine health management · 2026Article
- Colistin Resistance inAntibiotics (Basel, Switzerland) · 2026Article
- Global distribution of mcr-carrying bacteria: an analysis of genomic data.BMC medical genomics · 2026Article
- Perspectives on Colistin-An Old Antibiotic with Renewed Relevance in Modern Medicine.International journal of molecular sciences · 2026Review
- CharacterizingAntibiotics (Basel, Switzerland) · 2026Article
- Global genomic characteristics of mobile colistin resistance mcr genes in Enterobacterales from companion animals.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- High Prevalence of Multidrug-Resistant HaemolyticAntibiotics (Basel, Switzerland) · 2026Article
- Genomic characterization ofFrontiers in veterinary science · 2026Article
- Biochemical and genomic characterization of last-resort antibiotic resistance and oxidant tolerance in environmentalFrontiers in toxicology · 2026Article
- Unraveling the genome-wide repertoire of the novel chromosomally encodedFrontiers in microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colistin (polymyxin E) is a former exclusive veterinary antimicrobial and one of the oldest antibiotics that is currently recognized as one of the highest priority and critically important antimicrobials for human medicine. For food animals, colistin is extensively used for multiple medical and nonmedical purposes, particularly for growth promotion, prophylaxis/metaphylaxis, and therapeutic purposes. As a result, colistin resistance is widespread along the food chain and is linked to multidrug-resistant bacterial infections in humans. Furthermore, human medicine is more reliant on colistin for serious infections in healthcare settings. As a result, different types of national bans/restrictions in food- producing animals have been implemented around the world. Conclusions: The testimonies of 29 countries representing global initiatives to phase-out colistin use in animal production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.